Project Profile
In September 2021, Acctrue Technology and Shandong Bausch & Lomb - Freda Pharmaceutical Group Co., Ltd. officially reached a cooperation. This cooperation takes "one code for one item" as the basis, through UDI code assignment, medicine and device tracking, digital platform construction and other scenario requirements, to create a customized digital solution for Bausch & Lomb - Freda to trace the entire industry chain!
Challenges faced by Customer
Products with different code assignment standards cannot achieve compliance filing on the same platform;
The production line needs to be upgraded. The old line has low production efficiency and non-standard process;
Medical devices and medicines cannot share the production line, resulting in repeated investment;
Tracking data lag and cross region sale have seriously damaged the sales market.
Solutions
Through Acctrue’ s "medicine and device tracking" traceability platform system, the connection with the national medical device database has been realized up, the release and filing of product identification have been completed, the drug supervision and medical device data have been uniformly coded and managed, two coded servers of the medicine and medical device UDI have been docked down by selecting a uniform and standardized code assignment standard, and the supply chain business data has been collected and stored in the system, forming a data closed-loop of the whole chain of enterprise operation, and reacting on the business process according to the analysis of the role and behavior of each link, so as to form effective supervision, effect evaluation, intelligent prediction and other application mechanisms to serve the operation and management of Bausch & Lomb - Freda.
The system synchronously realizes the connection with the business documents of the WMS system of the on-site customers. In the aspect of warehouse management, the interconnection can be automatically generated when warehousing, and the information of warehouse outbound documents can be obtained to complete the data association between outbound and traceability code, and the traceability chain with upstream and downstream can be established, so as to improve the efficiency and accuracy of operators and reduce mis-delivery and other behaviors.
Through the on-site workshop inspection of Bausch & Lomb - Freda, the software environment and hardware environment assessment were carried out to ensure that the existing workshop layout would not be changed in the case of limited enterprise space, and the original drug production line of Bausch & Lomb - Freda was renovated to maximize the cost input of the factory while meeting the production needs of the factory, and to realize the co-line production mode of simultaneously producing the original drugs and existing medical device products on one line. The ease of use of the system is fully considered, the system mode is convenient to switch, and the production operation is simple.
Project achievements
1 Compliance supervision: it meets the regulatory compliance requirements of the NMPA on drug traceability and medical device UDI at the same time, and realizes the supervision and control of the whole process from production to terminal use of products.
2 Lower production cost: it realizes the co-line production mode that is compatible with the production of original drugs and existing medical device products in one line, effectively avoids the duplication of investment in the production line, and minimizes the production cost.
3 Improved stock accuracy: it helps the brand to achieve accurate inventory management through accurate and real-time monitoring of the flow rate of product flow, effectively improving the inventory accuracy and reducing manual errors.
4 Effective control of cross region sale: real-time monitoring and timely warning of abnormal cargo flow are effectively realized to ensure that all business processes are traceable, thus effectively improving the rate of cross region sale.